Login
Toggle navigation
Videos
Categories
Trending
Kidney Health Testing for People With Diabetes - Dr. Joseph Vassalotti, Chief Medical Officer
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Kidney Health Testing for People With Diabetes
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Abdullah Hil Rakib, Managing Director of TEAM Group, discusses how TTH is fostering leadership and its impact on the textile and apparel industry.
00:10:00
Yuri Milner Discusses Science, Tech Investments, and Global Impact | Yuri Milner, Founder, DST Global.
00:10:00
Our vision was to create a better hedge fund option that was truly clientâcentric|Cesar Bello, Partner,Corbin Capital Partners, L.P.
00:10:00
Employees on Comparably rated Rogers Corporation's company culture, providing their perspectives on the workplace environment.
00:10:00
Navigating Financial Services: Insights from Chris Flowers on Opportunities and Challenges
00:10:00
invests early growth capital in businesses that demonstrate a direct correlation between high impact and returns|Jyotsna Krishnan,Managing Partner,Elevar Equity
00:10:00
Awale Resources: Strategic Advancements and Promising Exploration in Côte d'Ivoire
00:10:00
Empowering Women in Finance: Sallie Krawcheck's Journey
00:00:00
Brent Barnes, CEO, LBT Innovations Ltd
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Deloitte CEO Joe Ucuzoglu Discusses Global Economic and Technological Trends | Joe Ucuzoglu, CEO , Deloitte.
00:10:00
Strategic Insights into Value Arbitrage Investing: A Discussion with Uri Landesman of Platinum Partners | Uri Landesman - President, Platinum Partners Value Arbitrage Fund LP